Medical Research
(H19)
990 on File
ZEBRAFISH DISEASE MODELS SOCIETY
Financial strength (30%)
80/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$194K
Total Revenue
$239K
Total Expenses
$189K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.5%
Fundraising Efficiency
N/A
Operating Reserve
9.52x
Liability-to-Asset
7.4%
Revenue Diversification
88.3%
Compared with Peers
FY 2023
Compared with 1,004 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.5% | 86.3% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.3% | 10.6% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.2% | 0.0% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.5 mo | 13.1 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
7.4% | 0.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
88.3% | 95.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-9.1% | 4.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-3.8% | 12.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-22.9% | -0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $194K | $239K | $189K | 86.5% | 0 |
| 2022 | $214K | $248K | $234K | 83.0% | 0 |
| 2021 | $148K | $107K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.